Stock Code: 301408 Stock Abbreviation: HuaRen Health Announcement No.: 2026-037
Anhui HuaRen Health Pharmaceutical Co., Ltd.
Announcement on Wholly-Owned Subsidiary Receiving Drug Registration Certificate
The Company and all members of the Board of Directors guarantee the content of this information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
Recently, Anhui HuaRen Health Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") wholly-owned subsidiary Jiangsu Shenhua Pharmaceutical Co., Ltd. received the approved and issued Drug Registration Certificate for Sacubitril Valsartan Sodium Tablets from the National Medical Products Administration (hereinafter referred to as the "NMPA"). The relevant situation is hereby announced as follows:
I. Basic Information of the Drug